[Acute encephalopathy caused by sulfadiazine and trimethoprim-sulfamethoxazole in a patient with AIDS].
A M
AM
Arjol
C
C
Sánchez
D
D
Dalmau
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000208:Acute Disease; D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000150:complications*; D003244:Consciousness Disorders / Q000139:chemically induced* / Q000209:etiology; D004198:Disease Susceptibility; D017809:Fatal Outcome; D006212:Hallucinations / Q000139:chemically induced / Q000209:etiology; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000150:complications*; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D013411:Sulfadiazine / Q000009:adverse effects* / Q000627:therapeutic use; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000188:drug therapy*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects* / Q000627:therapeutic use
D000890:Anti-Infective Agents; D013411:Sulfadiazine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination